brigatinib

Takeda’s ALUNBRIG gets FDA priority review for expanded indication in NSCLC
Pharmaceutical Business Review
Tue, 02/25/20 - 10:19 am
Takeda
Alunbrig
brigatinib
FDA
priority review
non-small cell lung cancer
3 Big Advances In Cancer Treatment In 2016
Motley Fool
Mon, 12/12/16 - 09:24 am
cancer
Merck
Keytruda
Kite Pharma
KTE-C19
Ariad Pharmaceuticals
brigatinib
Ariad Pharma Rises on FDA Decision
Yahoo/24-7 Wall St
Mon, 10/31/16 - 09:37 am
Ariad Pharma
FDA
brigatinib
non-small cell lung cancer
3 Cancer Drugs That Could Get an FDA OK Next Year
Motley Fool
Mon, 10/10/16 - 09:02 am
FDA
rucaparib
Clovis Oncology
ovarian cancer
binimetinib
Array Biopharma
melanoma
brigatinib
Ariad Pharmaceuticals
non-small cell lung cancer
Ariad appears on the upswing as investors renew hopes of a buyout
Bizjournals.com
Sat, 05/7/16 - 01:09 pm
Ariad Pharma
brigatinib
M&A